TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Imagion Biosystems Ltd. ( (AU:IBX) ).
Imagion Biosystems has successfully completed the first tranche of its $3.5 million capital raising, securing $0.675 million through the issuance of 45 million new ordinary shares. The second tranche, expected to raise an additional $2.8 million, is contingent upon shareholder approval at an upcoming Extraordinary General Meeting. This capital raising effort is part of Imagion’s strategy to advance its MagSense® imaging technology, which is designed to improve healthcare outcomes by enabling earlier and more precise detection of cancer cells.
More about Imagion Biosystems Ltd.
Imagion Biosystems is a company focused on developing non-radioactive and precision diagnostic molecular imaging technology. By integrating biotechnology and nanotechnology, the company aims to enhance the early detection of cancer and other diseases with greater specificity than current methods.
Average Trading Volume: 4,630,787
Technical Sentiment Signal: Sell
Current Market Cap: A$3.02M
For a thorough assessment of IBX stock, go to TipRanks’ Stock Analysis page.